Javascript must be enabled to continue!
Rapid-antigen testing for SARS-CoV-2 in Germany: Citizens’ selective granting of freedoms for negatively tested, vaccinated, recovered, and other citizens
View through CrossRef
Pandemic management of SARS-CoV-2 has involved temporary freedom restrictions to curb the spread of infection. In this study, citizens are asked for whom they would grant freedoms and it is examined how their granting is influenced by risk perceptions, and to what extent granting and individuals' test intentions are related to an understanding of test performance.When large-scale rapid-antigen testing was introduced as a means for pandemic management, we conducted a longitudinal study (March to May 2021) with a representative panel of German citizens who are online (N=4,991). We assessed granting of freedoms to participate in various activities (e.g., visiting restaurants) depending on health status (negative rapid antigen test, vaccinated, recovered from COVID-19, or neither), and respondents’ understanding of the performance of rapid antigen tests. An experiment with the panel (N=1,660, May 2021) investigated how information from a national health authority on the societal benefit of regular testing and on test performance relate to respondents’ test comprehension and freedom granting.Granting for tested and vaccinated people was associated with their perceived infectivity. Substantial freedoms were only granted for negatively tested and vaccinated citizens, until in May 2021 recovered people were roughly put on par with those groups. Restricting activities for other citizens who fulfilled none of these criteria remained highly accepted. Providing evidence-based information improved comprehension of test performance over a control group without information and decreased granting for negatively tested groups. Adding societal benefit information mediated this decrease in granting. Respondents testing intentions were not affected by the provided information. Citizens were uncertain about both infectivity risks and test properties. Presenting them with performance information improved understanding of test performance and reduced freedom granting for negatively tested people. Evidence-based information has the potential to inform a critical acceptance of targeted granting of freedoms as a measure of pandemic management.
Title: Rapid-antigen testing for SARS-CoV-2 in Germany: Citizens’ selective granting of freedoms for negatively tested, vaccinated, recovered, and other citizens
Description:
Pandemic management of SARS-CoV-2 has involved temporary freedom restrictions to curb the spread of infection.
In this study, citizens are asked for whom they would grant freedoms and it is examined how their granting is influenced by risk perceptions, and to what extent granting and individuals' test intentions are related to an understanding of test performance.
When large-scale rapid-antigen testing was introduced as a means for pandemic management, we conducted a longitudinal study (March to May 2021) with a representative panel of German citizens who are online (N=4,991).
We assessed granting of freedoms to participate in various activities (e.
g.
, visiting restaurants) depending on health status (negative rapid antigen test, vaccinated, recovered from COVID-19, or neither), and respondents’ understanding of the performance of rapid antigen tests.
An experiment with the panel (N=1,660, May 2021) investigated how information from a national health authority on the societal benefit of regular testing and on test performance relate to respondents’ test comprehension and freedom granting.
Granting for tested and vaccinated people was associated with their perceived infectivity.
Substantial freedoms were only granted for negatively tested and vaccinated citizens, until in May 2021 recovered people were roughly put on par with those groups.
Restricting activities for other citizens who fulfilled none of these criteria remained highly accepted.
Providing evidence-based information improved comprehension of test performance over a control group without information and decreased granting for negatively tested groups.
Adding societal benefit information mediated this decrease in granting.
Respondents testing intentions were not affected by the provided information.
Citizens were uncertain about both infectivity risks and test properties.
Presenting them with performance information improved understanding of test performance and reduced freedom granting for negatively tested people.
Evidence-based information has the potential to inform a critical acceptance of targeted granting of freedoms as a measure of pandemic management.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Abstarct
Introduction
Orbital hydatid cysts (HCs) constitute less than 1% of all cases of hydatidosis, yet their occurrence is often linked to severe visual complications. This stu...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Kinetics of the humoral immune response to SARS-CoV-2: comparative analytical performance of seven commercial serology tests
Abstract
Background
SARS-CoV-2 serology tests are clinically useful to document a prior SARS-CoV-2 infection in patients with n...
Diagnostic Efficacy of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) study
Diagnostic Efficacy of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) study
Abstract
Background
Widely available rapid testing is pivotal to the fight against COVID-19. Real-time reverse transcription-po...
Mutations in SARS-CoV
Mutations in SARS-CoV
The coronavirus family is named for the large spike protein molecules found
on the pathogen exterior, which give the virus a crown-like appearance, the coronavirus
genome is the bi...
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes
AbstractBackgroundSevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to...

